Lipemia: causes, interference mechanisms, detection and management

In the clinical laboratory setting, interferences can be a significant source of laboratory errors with potential to cause serious harm for the patient. After hemolysis, lipemia is the most frequent endogenous interference that can influence results of various laboratory methods by several mechanisms. The most common preanalytical cause of lipemic samples is inadequate time of blood sampling after the meal or parenteral administration of synthetic lipid emulsions. Although the best way of detecting the degree of lipemia is measuring lipemic index on analytical platforms, laboratory experts should be aware of its problems, like false positive results and lack of standardization between manufacturers. Unlike for other interferences, lipemia can be removed and measurement can be done in a clear sample. However, a protocol for removing lipids from the sample has to be chosen carefully, since it is dependent on the analytes that have to be determined. Investigation of lipemia interference is an obligation of manufacturers of laboratory reagents; however, several literature findings report lack of verification of the declared data. Moreover, the acceptance criteria currently used by the most manufacturers are not based on biological variation and need to be revised. Written procedures for detection of lipemia, removing lipemia interference and reporting results from lipemic samples should be available to laboratory staff in order to standardize the procedure, reduce errors and increase patient safety.

[1]  Bhawna Singh,et al.  Evaluation of errors in a clinical laboratory: a one-year experience , 2010, Clinical chemistry and laboratory medicine.

[2]  A. Sharma,et al.  Flocculation of serum lipoproteins with cyclodextrins: application to assay of hyperlipidemic serum. , 1990, Clinical chemistry.

[3]  G. Lippi,et al.  Hemolysis, lipaemia and icterus in specimens for arterial blood gas analysis. , 2012, Clinical biochemistry.

[4]  G Lippi,et al.  Standardization of collection requirements for fasting samples: for the Working Group on Preanalytical Phase (WG-PA) of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM). , 2014, Clinica chimica acta; international journal of clinical chemistry.

[5]  A. Šimundić,et al.  The evaluation and comparison of consecutive high speed centrifugation and LipoClear® reagent for lipemia removal. , 2014, Clinical biochemistry.

[6]  A. Lyon,et al.  Pseudohyponatremia in a Myeloma Patient: Direct Electrode Potentiometry is a Method Worth its Salt , 2003 .

[7]  A. Burlina,et al.  Glycerol Metabolism and the Determination of Triglycerides –Clinical, Biochemical and Molecular Findings in Six Subjects , 2003, Clinical chemistry and laboratory medicine.

[8]  Nora Nikolac,et al.  The prevalence of preanalytical errors in a Croatian ISO 15189 accredited laboratory , 2010, Clinical chemistry and laboratory medicine.

[9]  S. Kazmierczak Hemolysis, Lipemia, and High Bilirubin: Effect on Laboratory Tests , 2013 .

[10]  K. Sztefko,et al.  [Interferences in immunoassay]. , 2012, Przeglad lekarski.

[11]  W. Oosterhuis,et al.  Detection of a monoclonal gammopathy by lipemia-index measurement , 2022 .

[12]  G. Dimeski,et al.  Lipaemic samples: effective process for lipid reduction using high speed centrifugation compared with ultracentrifugation. , 2011, Biochemia medica.

[13]  W. Oosterhuis,et al.  Detection of a monoclonal gammopathy by serum index measurement , 2009, Clinical chemistry and laboratory medicine.

[14]  Qing H Meng,et al.  Evaluation of the interference of hemoglobin, bilirubin, and lipids on Roche Cobas 6000 assays. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[15]  M. Bucklin,et al.  Prolonged lipemia and pancreatitis due to extended infusion of lipid emulsion in bupropion overdose , 2013, Clinical toxicology.

[16]  Nora Nikolac,et al.  Heterogeneity of manufacturers' declarations for lipemia interference--an urgent call for standardization. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[17]  Nora Nikolac,et al.  Preanalytical quality improvement: in quality we trust , 2013, Clinical chemistry and laboratory medicine.

[18]  T. Pillay,et al.  Pseudohyponatremia revisited: a modern-day pitfall. , 2011, Archives of pathology & laboratory medicine.

[19]  N. Blanckaert,et al.  Serum protein electrophoresis by CZE 2000 clinical capillary electrophoresis system. , 1998, Clinical chemistry.

[20]  D. Darby,et al.  Interference with serum indices measurement, but not chemical analysis, on the Roche Modular by Patent Blue V , 2008, Annals of clinical biochemistry.

[21]  A. Jenkins,et al.  Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. , 2003, Diabetes.

[22]  K. Ryder,et al.  Graphical comparisons of interferences in clinical chemistry instrumentation. , 1986, Clinical chemistry.

[23]  K. Knudsen,et al.  Use of intravenous lipid emulsion in the resuscitation of a patient with cardiovascular collapse after a severe overdose of quetiapine , 2013, Clinical toxicology.

[24]  Tianyang Ren,et al.  Lipid emulsions in parenteral nutrition: current applications and future developments , 2013, Expert opinion on drug delivery.

[25]  G. Steen,et al.  Correction of patient results for Beckman Coulter LX-20 assays affected by interference due to hemoglobin, bilirubin or lipids: a practical approach , 2007, Clinical chemistry and laboratory medicine.

[26]  Greg Ward,et al.  Interferences in immunoassay. , 2004, The Clinical biochemist. Reviews.

[27]  R. F. Roberts,et al.  Assay-specific differences in lipemic interference in native and intralipid-supplemented samples. , 2004, Clinical chemistry.

[28]  M. Kroll Evaluating interference caused by lipemia. , 2004, Clinical chemistry.

[29]  C. M. D. de Cordova,et al.  Interference on the laboratory measurement of bilirubin: the effect of in vitro interactions. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[30]  J O Westgard,et al.  Criteria for judging precision and accuracy in method development and evaluation. , 1974, Clinical chemistry.

[31]  Mario Plebani,et al.  Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories , 2008, Clinical chemistry and laboratory medicine.

[32]  M. Panteghini,et al.  Hemoglobin, bilirubin, and lipid interference on Roche Cobas 6000 assays. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[33]  Effects of hemolysis and lipemia on the COBAS salicylate and acetaminophen assays compared to GDS assays. , 2008, Clinical biochemistry.

[34]  Gerard Steen,et al.  Multicenter evaluation of the interference of hemoglobin, bilirubin and lipids on Synchron LX-20 assays , 2006, Clinical chemistry and laboratory medicine.

[35]  G. Lippi,et al.  Interference in Coagulation Testing: Focus on Spurious Hemolysis, Icterus, and Lipemia , 2012, Seminars in Thrombosis & Hemostasis.

[36]  A. Šimundić,et al.  Comparison of visual vs. automated detection of lipemic, icteric and hemolyzed specimens: can we rely on a human eye? , 2009, Clinical chemistry and laboratory medicine.

[37]  P. Twomey,et al.  Unreliability of triglyceride measurement to predict turbidity induced interference , 2003, Journal of clinical pathology.

[38]  G. Lippi,et al.  Patient Safety and Quality in Laboratory and Hemostasis Testing: A Renewed Loop? , 2012, Seminars in Thrombosis & Hemostasis.

[39]  M H Kroll,et al.  Interference with clinical laboratory analyses. , 1994, Clinical chemistry.

[40]  A. Šimundić,et al.  Preanalytical quality improvement: from dream to reality , 2011, Clinical chemistry and laboratory medicine.

[41]  G. Kim Pseudohyponatremia: Does It Matter in Current Clinical Practice? , 2006, Electrolyte & blood pressure : E & BP.

[42]  S. Gosselin,et al.  Analytical interferences resulting from intravenous lipid emulsion , 2012, Clinical toxicology.

[43]  N. Kamatani,et al.  Influences of ethanol on 5-phosphoribosyl-1-pyrophosphate concentration and purine-metabolizing enzyme activities in the mouse liver. , 1979, Biochemical medicine.

[44]  C. McCudden,et al.  Endogenous Interferences in Clinical Laboratory Tests: Icteric, Lipemic and Turbid Samples , 2012 .

[45]  C Ricós,et al.  Current databases on biological variation: pros, cons and progress. , 1999, Scandinavian journal of clinical and laboratory investigation.

[46]  A. Verstraete,et al.  An unusual case of (pseudo)hypertriglyceridaemia , 2010, NDT plus.

[47]  M. Gorenjak,et al.  Investigation of unusual high serum indices for lipemia in clear serum samples on Siemens analysers Dimension , 2012, Biochemia medica.

[48]  J. Delanghe,et al.  Comparison of triglyceride concentration with lipemic index in disorders of triglyceride and glycerol metabolism , 2006, Clinical chemistry and laboratory medicine.

[49]  P. Calmarza,et al.  Lipemia interferences in routine clinical biochemical tests. , 2011, Biochemia medica.

[50]  A. Šimundić,et al.  Are patients well informed about the fasting requirements for laboratory blood testing? , 2013, Biochemia medica.

[51]  A. Šimundić,et al.  Croatian Society of Medical Biochemistry and Laboratory Medicine: national recommendations for venous blood sampling , 2013, Biochemia medica.

[52]  K. Ryder,et al.  Unreliable visual estimation of the incidence and amount of turbidity, hemolysis, and icterus in serum from hospitalized patients. , 1989, Clinical chemistry.

[53]  D. Porquet,et al.  [Haemolysis and turbidity influence on three analysis methods of quantitative determination of total and conjugated bilirubin on ADVIA 1650]. , 2008, Annales de biologie clinique.